Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies
The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.
Abstract
Continuously increasing understanding of the molecular triggers responsible for the onset of diseases, paralleled by an equally dynamic evolution of chemical synthesis and screening methods, offers an abundance of pharmacological agents with a potential to become new successful drugs. However, before patients can benefit of newly developed pharmaceuticals, stringent safety filters need to be applied to weed out unfavourable drug candidates. Cost effectiveness and the need to identify compound liabilities, without exposing humans to unnecessary risks, has stimulated the shift of the safety studies to the earliest stages of drug discovery and development. In this regard, in vivo relevant organotypic in vitro models have high potential to revolutionize the preclinical safety testing. They can enable automation of the process, to match the requirements of high-throughput screening approaches, while satisfying ethical considerations. Cultures of primary hepatocytes became already an inherent part of the preclinical pharmaco-toxicological testing battery, yet their routine use, particularly for long-term assays, is limited by the progressive deterioration of liver-specific features. The availability of suitable hepatic and other organ-specific in vitro models is, however, of paramount importance in the light of changing European legal regulations in the field of chemical compounds of different origin, which gradually restrict the use of animal studies for safety assessment, as curr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Although scarcely distributed, the ECM is an integral part of the complex liver architecture and the restoration of cell-ECM contacts is crucial for the preservation of the differentiated hepatic phenotype in cell culture (Fraczek et al., 2013[12]; Ye et al., 2019[48]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Fraczek et al., 2013[12]
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
In the citing paper
“HNF1α, C/EBP and HNF1β were amongst the most significantly associated regulators with the loss of metabolic competence.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
Citations
Cites
1 retracted
Datta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 2×
“Besides altering the physical properties of chromatin, addition or removal of acetyl groups also modifies the array of posttranslational modifications of amino acids in the histones’ tails, which is believed to create a specific code, designated as the ‘histone code’ (Strahl and Allis 2000).”
BackgroundOkano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Chapter 4 Preparation of Isolated Rat Liver Cells
Seglen, P. O. (1976) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61797-5 · Cited by 5,310 · cited 2×
“Further detachment of cells from the extracellular matrix (ECM) backbone is achieved in a second step by perfusion with a collagenase solution (Seglen 1976; Papeleu et al. 2006a).”
BackgroundMethodThe Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807 · cited 1×
“000 lives are annually lost because of ADRs, while medical costs of treating their consequences translate into billions of dollars (Lazarou et al. 1998).”
BackgroundHIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167 · cited 4×
“Indeed, in the early 90s, unsatisfactory efficacy and pharmacokinetics were identified as the most prominent causes of drug attrition (Kola and Landis 2004; Schuster et al. 2005).”
BackgroundInfluentialLysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006) · Nature · doi:10.1038/nature05063 · Cited by 2,102
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Matrigel: A complex protein mixture required for optimal growth of cell culture
Hughes, C. S., Postovit, L. M., & Lajoie, G. A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900758 · Cited by 1,534
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, P. A., Gifford, D. K., et al. (2004) · Science · doi:10.1126/science.1089769 · Cited by 1,321
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
Stoker, M., Gherardi, E., Perryman, M., & Gray, J. (1987) · Nature · doi:10.1038/327239a0 · Cited by 1,314
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Methylation of tRNA Asp by the DNA Methyltransferase Homolog Dnmt2
Goll, M. G., Kirpekar, F., Maggert, K. A., Yoder, J. A., Hsieh, C.-L., Zhang, X., Golic, K. G., Jacobsen, S. E., & Bestor, T. H. (2006) · Science · doi:10.1126/science.1120976 · Cited by 1,190
DNA methylation and gene silencing in cancer
Baylin, S. B. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0354 · Cited by 1,154 · cited 1×
“genomic DNA, usually unmethylated, and are associated with active gene expression (Baylin 2005; Szyf 2010).”
BackgroundSladek, F. M., Zhong, W. M., Lai, E., & Darnell, J. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2353 · Cited by 1,027
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
Eberharter, A., & Becker, P. B. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf053 · Cited by 948
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
Wahid, F., Shehzad, A., Khan, T., & Kim, Y. Y. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.013 · Cited by 899
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“However, the most commonly used hepatic cell line, that is, human hepatoma HepG2 cells, undergoes a substantial loss of liver cell functions, particularly the expression of phase I (CYPs) enzymes and drug transporters is decreased (Boess et al. 2003; Castell et al. 2006; Harris et al. 2004; Wang et al. 2002; Wilkening…”
BackgroundGarzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Aninat, C., Piton, A., Glaise, D., Le Charpentier, T., Langouët, S., Morel, F., Guguen-Guillouzo, C., & Guillouzo, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006759 · Cited by 703
Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration
Dunn, J. C. Y., Tompkins, R. G., & Yarmush, M. L. (1991) · Biotechnology Progress · doi:10.1021/bp00009a007 · Cited by 694 · cited 3×
“In addition, an improved constitutive and inducible expression of phase I and II biotransformation enzymes and their upstream transcriptional regulators were also observed (Farkas et al. 2005; Farkas and Tannenbaum 2005; Tuschl and Mueller 2006; Lasher et al. 2011; Kim et al. 2010; Dunn et al. 1991; LeCluyse et al. 19…”
BackgroundMethodHDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen-Guillouzo, C. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 675
Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjärn, M., Hansen, J. B., Hansen, H. F., Straarup, E. M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1113 · Cited by 672
Chuang, J. C., & Jones, P. A. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180457684 · Cited by 668
(1996) · Europe PMC (PubMed Central) · Cited by 659
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Biological functions of microRNAs: a review
Huang, Y., Shen, X. J., Zou, Q., Wang, S. P., Tang, S. M., & Zhang, G. Z. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0050-6 · Cited by 652
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
VAISSIERE, T., SAWAN, C., & HERCEG, Z. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.02.004 · Cited by 636
Activation of PPARγ Coactivator-1 Through Transcription Factor Docking
Puigserver, P., Adelmant, G., Wu, Z., Fan, M., Xu, J., O'Malley, B., & Spiegelman, B. M. (1999) · Science · doi:10.1126/science.286.5443.1368 · Cited by 596
Zonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589
Parviz, F., Matullo, C., Garrison, W. D., Savatski, L., Adamson, J. W., Ning, G., Kaestner, K. H., Rossi, J. M., Zaret, K. S., & Duncan, S. A. (2003) · Nature Genetics · doi:10.1038/ng1175 · Cited by 588
MacSween, N. M. R. (1979) · Churchill Livingstone eBooks · Cited by 575
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Costa, R. H., Grayson, D. R., & Darnell, J. E. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1415 · Cited by 539
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Hideshima, T., Akiyama, M., Chauhan, D., Munshi, N., Gu, X., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536759100 · Cited by 531
Landry, J., Bernier, D., Ouellet, C., Goyette, R., & Marceau, N. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.914 · Cited by 520
(2003) · PubMed · Cited by 519
GUGUENGUILLOUZO, C., CLEMENT, B., BAFFET, G., BEAUMONT, C., MORELCHANY, E., GLAISE, D., & GUILLOUZO, A. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90107-6 · Cited by 519
Liver‐enriched transcription factors and hepatocyte differentiation
Cereghini, S. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.2.8641560 · Cited by 510 · cited 1×
“In the liver, LETFs play a cardinal role by controlling the expression of a broad range of genes across the entire hepatocyte biochemistry including genes encoding the effectors of intermediary metabolism, urea cycle, as well as plasma proteins and coagulation factors (Table 5) (Cereghini 1996; Johnson 1990; Gonzalez…”
BackgroundMammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.
(2000) · PubMed Central · Cited by 489
AdoMet-dependent methylation, DNA methyltransferases and base flipping
Cheng, X. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3784 · Cited by 485
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478
Managing the challenge of chemically reactive metabolites in drug development
Park, B. K., Boobis, A., Clarke, S., Goldring, C. E. P., Jones, D., Kenna, J. G., Lambert, C., Laverty, H. G., Naisbitt, D. J., Nelson, S., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 462
Interaction of a Liver-Specific Nuclear Factor with the Fibrinogen and α 1 -Antitrypsin Promoters
Courtois, G., Morgan, J. G., Campbell, L. A., Fourel, G., & Crabtree, G. R. (1987) · Science · doi:10.1126/science.3499668 · Cited by 460
Mammalian hepatocyte differentiation requires the transcription factor HNF-4α
Li, J., Ning, G., & Duncan, S. A. (2000) · Genes & Development · doi:10.1101/gad.14.4.464 · Cited by 458
The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
Tirona, R. G., Lee, W., Leake, B. F., Lan, L.-B., Cline, C. B., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., et al. (2003) · Nature Medicine · doi:10.1038/nm815 · Cited by 440
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420 · cited 2×
“It is thus not astonishing that the loss of hepatocyte-specific functions during primary hepatocyte cultivation is mirrored by a concurrent abrogation of expression of LETFs (Rodriguez-Antona et al. 2002).”
BackgroundWhy Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417 · cited 3×
“Consequently, the pharmaceutical industry integrated ADMET testing in preclinical studies, majorly supported by technological advances in the area of molecular biology (Tsaioun and Jacewicz 2009; Kola and Landis 2004; Schuster et al. 2005).”
Backgroundde Graaf, I. A. M., Olinga, P., de Jager, M. H., Merema, M. T., de Kanter, R., van de Kerkhof, E. G., & Groothuis, G. M. M. (2010) · Nature Protocols · doi:10.1038/nprot.2010.111 · Cited by 411
Rappaport, A. M., Borowy, Z. J., Lougheed, W. M., & Lotto, W. N. (1954) · The Anatomical Record · doi:10.1002/ar.1091190103 · Cited by 400 · cited 1×
“The latter structure represents a rudimentary functional unit of the liver, which reflects well the hepatic microcirculation (Rappaport et al. 1954; Burt and Day 2002).”
BackgroundGuo, C., Sah, J. F., Beard, L., Willson, J. K. V., Markowitz, S. D., & Guda, K. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20596 · Cited by 396
Mammalian DNA Methyltransferases: A Structural Perspective
Cheng, X., & Blumenthal, R. M. (2008) · Structure · doi:10.1016/j.str.2008.01.004 · Cited by 394
Braconi, C., Huang, N., & Patel, T. (2010) · Hepatology · doi:10.1002/hep.23381 · Cited by 376
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Szyf, M. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103102 · Cited by 374 · cited 3×
“The established DNA methylation patterns, generated by DNMTs, produce a strictly cell-inherent and tissue type-specific epigenetic fingerprint (Szyf 2009).”
BackgroundMethodInfluentialProcaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.
Villar‐Garea, A., Fraga, M. F., Espada, J., & Esteller, M. (2003) · PubMed · Cited by 373
Maintenance of differentiated rat hepatocytes in primary culture.
Isom, H. C., Secott, T., Georgoff, I., Woodworth, C., & Mummaw, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3252 · Cited by 358
Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies
Kanebratt, K. P., & Andersson, T. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.020016 · Cited by 354
Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells
Chen, T., Hevi, S., Gay, F., Tsujimoto, N., He, T., Zhang, B., Ueda, Y., & Li, E. (2007) · Nature Genetics · doi:10.1038/ng1982 · Cited by 353
HDAC inhibitors: Clinical update and mechanism-based potential
Glaser, K. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.007 · Cited by 348
Chromatin modifier enzymes, the histone code and cancer
Santos-Rosa, H., & Caldas, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.010 · Cited by 337
Kang, L., Chung, B. G., Langer, R., & Khademhosseini, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.003 · Cited by 325
Human Hepatic Stem Cell and Maturational Liver Lineage Biology Δ
Turner, R., Lozoya, O., Wang, Y., Cardinale, V., Gaudio, E., Alpini, G., Mendel, G., Wauthier, E., Barbier, C., Alvaro, D., et al. (2011) · Hepatology · doi:10.1002/hep.24157 · Cited by 322
The Role of Cis-Acting Promoter Elements in Tissue-Specific Albumin Gene Expression
Maire, P., Wuarin, J., & Schibler, U. (1989) · Science · doi:10.1126/science.2711183 · Cited by 314
Gowher, H., Liebert, K., Hermann, A., Xu, G., & Jeltsch, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413412200 · Cited by 310
Interplay between microRNAs and the epigenetic machinery: An intricate network
Iorio, M. V., Piovan, C., & Croce, C. M. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.005 · Cited by 306
Boess, F. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg064 · Cited by 306
Microfabrication of Hepatocyte/Fibroblast Co-cultures: Role of Homotypic Cell Interactions
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1998) · Biotechnology Progress · doi:10.1021/bp980036j · Cited by 304
Structure and dynamic behavior of nucleosomes
Luger, K. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00026-1 · Cited by 300
Elaut, G., Henkens, T., Papeleu, P., Snykers, S., Vinken, M., Vanhaecke, T., & Rogiers, V. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017759 · Cited by 292
Self-citationKyrmizi, I., Hatzis, P., Katrakili, N., Tronche, F., Gonzalez, F. J., & Talianidis, I. (2006) · Genes & Development · doi:10.1101/gad.390906 · Cited by 285
Schrem, H., Klempnauer, J., & Borlak, J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.129 · Cited by 283
Mietus-Snyder, M., Sladek, F. M., Ginsburg, G. S., Kuo, C. F., Ladias, J. A., Darnell, J. E., & Karathanasis, S. K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1708 · Cited by 281
Zhang, Y., He, Y., Bharadwaj, S., Hammam, N., Carnagey, K., Myers, R., Atala, A., & Van Dyke, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.005 · Cited by 276
Hodawadekar, S. C., & Marmorstein, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210619 · Cited by 272
LeCluyse, E. L., Audus, K. L., & Hochman, J. H. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.6.c1764 · Cited by 266
Laishes, B. A., & Williams, G. M. (1976) · In Vitro · doi:10.1007/bf02796495 · Cited by 263
Regulating histone acetyltransferases and deacetylases
Legube, G., & Trouche, D. (2003) · EMBO reports · doi:10.1038/sj.embor.embor941 · Cited by 260
Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold
Chua, K.-N., Lim, W.-S., Zhang, P., Lu, H., Wen, J., Ramakrishna, S., Leong, K. W., & Mao, H.-Q. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.040 · Cited by 258
Im, J.-Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.3 · Cited by 247
Making Better Drugs: Decision Gates in Non-Clinical Drug Development
Pritchard, J. F., Jurima-Romet, M., Reimer, M. L. J., Mortimer, E., Rolfe, B., & Cayen, M. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1131 · Cited by 246
Battle, M. A., Konopka, G., Parviz, F., Gaggl, A. L., Yang, C., Sladek, F. M., & Duncan, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600246103 · Cited by 246
XXIX. The anatomy and physiology of the liver
Kiernan, F. (1833) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1833.0031 · Cited by 240
New Insights into Functional Aspects of Liver Morphology
Malarkey, D. E., Johnson, K., Ryan, L., Boorman, G., & Maronpot, R. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590881826 · Cited by 236
Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor
Powers, M. J., Janigian, D. M., Wack, K. E., Baker, C. S., Stolz, D. B., & Griffith, L. G. (2002) · Tissue Engineering · doi:10.1089/107632702760184745 · Cited by 234
Epigenetics and cancer treatment
Kristensen, L. S., Nielsen, H. M., & Hansen, L. L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.011 · Cited by 230
O'Brien, R. M., Noisin, E. L., Suwanichkul, A., Yamasaki, T., Lucas, P. C., Wang, J.-C., Powell, D. R., & Granner, D. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1747 · Cited by 226
Monaci, P., Nicosia, A., & Cortese, R. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03047.x · Cited by 226
Modulation of functional activities in cultured rat hepatocytes
Guguen-Guillouzo, C., & Guillouzo, A. (1983) · Molecular and Cellular Biochemistry · doi:10.1007/bf00225245 · Cited by 217 · cited 1×
“Unfortunately, increased protein degradation and decreased protein synthesis are negative consequences associated with the use of glucagon (Guguen-Guillouzo and Guillouzo 1983; Dich et al. 1988).”
BackgroundRational Combinations Using HDAC Inhibitors
Bots, M., & Johnstone, R. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2786 · Cited by 217
Jover, R. (2001) · Hepatology · doi:10.1053/jhep.2001.22176 · Cited by 216
HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans
Kanebratt, K. P., & Andersson, T. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017418 · Cited by 214
Park, E. A., Roesler, W. J., Liu, J., Klemm, D. J., Gurney, A. L., Thatcher, J. D., Shuman, J., Friedman, A., & Hanson, R. W. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6264 · Cited by 213
Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies
Castell, J. V., Jover, R., Martnez-Jimnez, C. P., & Gmez-Lechn, M. J. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.2.183 · Cited by 212
De novo CpG Island Methylation in Human Cancer Cells
Jair, K.-W., Bachman, K. E., Suzuki, H., Ting, A. H., Rhee, I., Yen, R.-W. C., Baylin, S. B., & Schuebel, K. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1980 · Cited by 210
CpG Island Hypermethylation of Tumor Suppressor microRNAs in Human Cancer
Lujambio, A. (2007) · Cell Cycle · doi:10.4161/cc.6.12.4408 · Cited by 210
Micrornas Control Hepatocyte Proliferation During Liver Regeneration
Song, G., Sharma, A. D., Roll, G. R., Ng, R., Lee, A. Y., Blelloch, R. H., Frandsen, N. M., & Willenbring, H. (2010) · Hepatology · doi:10.1002/hep.23547 · Cited by 207
CpG Island Hypermethylation of Tumor Suppressor Genes in Human Cancer
Herranz, M., & Esteller, M. (2007) · Medical Intelligence Unit · doi:10.1007/0-387-27443-x_6 · Cited by 202
Zuo, Y., Qiang, L., & Farmer, S. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510682200 · Cited by 201
Ferguson, S. S., Chen, Y., LeCluyse, E. L., Negishi, M., & Goldstein, J. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013169 · Cited by 200
Masprone (1979) · Archive of European Integration (AEI) (University of Pittsburgh) · Cited by 199
The FoxA factors in organogenesis and differentiation
Kaestner, K. H. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.06.005 · Cited by 197
Regulation of Hepatocyte Nuclear Factor 4α-mediated Transcription
Gonzalez, F. J. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.2 · Cited by 194
Core transcriptional regulatory circuitry in human hepatocytes
Odom, D. T., Dowell, R. D., Jacobsen, E. S., Nekludova, L., Rolfe, P. A., Danford, T. W., Gifford, D. K., Fraenkel, E., Bell, G. I., & Young, R. A. (2006) · Molecular Systems Biology · doi:10.1038/msb4100059 · Cited by 194 · cited 1×
“This complex net of interactions between LETFs and their target genes becomes even more intricate through the mechanism of LETFs auto- and crossregulation (Hayashi et al. 1999; Odom et al. 2006; Kyrmizi et al. 2006).”
BackgroundLeCluyse, E. L., Bullock, P. L., & Parkinson, A. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00418-8 · Cited by 193
Reconstitution and Mechanism of the Stimulation of de Novo Methylation by Human DNMT3L
Kareta, M. S., Botello, Z. M., Ennis, J. J., Chou, C., & Chédin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603140200 · Cited by 190
Clement, B., Guguen-Guillouzo, C., Campion, J.-P., Glaise, D., Bourel, M., & Guillouzo, A. (1984) · Hepatology · doi:10.1002/hep.1840040305 · Cited by 188
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
Marks, P. A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.008 · Cited by 187
microRNAs and the regulation of glucose and lipid metabolism
Poy, M. N., Spranger, M., & Stoffel, M. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00775.x · Cited by 186
Probing heterotypic cell interactions: Hepatocyte function in microfabricated co-cultures
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1998) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856298x00695 · Cited by 184
Marquez, R. T., Wendlandt, E., Galle, C. S., Keck, K., & McCaffrey, A. P. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00338.2009 · Cited by 182
Lin, X., Asgari, K., PUTZI, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., Marzo, A. M. D., et al. (2001) · PubMed · Cited by 180
Histone deacetylases—an important class of cellular regulators with a variety of functions
Hildmann, C., Riester, D., & Schwienhorst, A. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0911-2 · Cited by 180
Bolotin, E., Liao, H., Ta, T. C., Yang, C., Hwang-Verslues, W., Evans, J. R., Jiang, T., & Sladek, F. M. (2010) · Hepatology · doi:10.1002/hep.23357 · Cited by 172
Rausa, F., Samadani, U., Ye, H., Lim, L., Fletcher, C. F., Jenkins, N. A., Copeland, N. G., & Costa, R. H. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8744 · Cited by 169
Calpains Can Do It Alone: Implications for Cancer Therapy
guicciardi, M. E., & Gores, G. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.349 · Cited by 164
Schaefer, M., & Lyko, F. (2010) · Chromosoma · doi:10.1007/s00412-009-0240-6 · Cited by 163
Dual targeting of epigenetic therapy in cancer
Hellebrekers, D. M. E. I., Griffioen, A. W., & van Engeland, M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.07.003 · Cited by 161
Guo, L., Liu, Y., Bai, Y., Sun, Y., Xiao, F.-M., & Guo, Y. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.043 · Cited by 158
Wortham, M., Czerwiński, M., He, L., Parkinson, A., & Wan, Y. Y. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016436 · Cited by 157
Histone deacetylase inhibitors as anti-neoplastic agents
Batty, N., Malouf, G. G., & Issa, J. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.013 · Cited by 156
Bioartificial liver systems: current status and future perspective
Park, J.-K., & Lee, D. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.311 · Cited by 155
Yamashita, Y., Shimada, M., Harimoto, N., Rikimaru, T., Shirabe, K., Tanaka, S., & Sugimachi, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.10699 · Cited by 155
Regulating the Regulators: The Post‐Translational Code of Class I HDAC1 and HDAC2
Segré, C. V., & Chiocca, S. (2011) · BioMed Research International · doi:10.1155/2011/690848 · Cited by 153
Conditions affecting primary cell cultures of functional adult rat hepatocytes
Laishes, B. A., & Williams, G. M. (1976) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02796367 · Cited by 152
Dannenberg, L. O., & Edenberg, H. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-181 · Cited by 150
LeCluyse, E. L., Bullock, P. L., Parkinson, A., & Hochman, J. H. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_9 · Cited by 147
Goulet, F., Normand, C., & Morin, O. (1988) · Hepatology · doi:10.1002/hep.1840080506 · Cited by 147
SRC-1 and GRIP1 Coactivate Transcription with Hepatocyte Nuclear Factor 4
Wang, J.-C., Stafford, J. M., & Granner, D. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30847 · Cited by 147
HNF4α—role in drug metabolism and potential drug target?
Hwang-Verslues, W. W., & Sladek, F. M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.010 · Cited by 146
Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix
Lang, R., Stern, M. M., Smith, L., Liu, Y., Bharadwaj, S., Liu, G., Baptista, P. M., Bergman, C. R., Söker, S., Yoo, J. J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.005 · Cited by 144
The Transcriptional Activator Hepatocyte Nuclear Factor 6 Regulates Liver Gene Expression
Samadani, U., & Costa, R. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6273 · Cited by 144
Morin, O., & Normand, C. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041290115 · Cited by 144
Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes
Baker, T. K., Carfagna, M. A., Gao, H., Dow, E. R., Li, Q., Searfoss, G. H., & Ryan, T. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx015518a · Cited by 143
Späth, G. F., & Weiss, M. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.935 · Cited by 141
Transcription factor‐dependent regulation of CBP and P/CAF histone acetyltransferase activity
Soutoglou, E., Viollet, B., Vaxillaire, M., Yaniv, M., Pontoglio, M., & Talianidis, I. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1984 · Cited by 139
Archaeal histones and the origin of the histone fold
Sandman, K., & Reeve, J. N. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.003 · Cited by 134
Goral, V. N., Hsieh, Y.-C., Petzold, O. N., Clark, J. S., Yuen, P. K., & Faris, R. A. (2010) · Lab on a Chip · doi:10.1039/c0lc00135j · Cited by 130 · cited 1×
“Microchannels with integrated biomimetic 3D scaffolds on which hepatocytes are seeded, as often seen in microfluidic cell culture systems, are also an example of cellular micropatterning (Goral et al. 2010; Goral and Yuen 2011).”
BackgroundRe‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells
Jover, R., Bort, R., Gómez-Lechón, M. J., & Castell, J. V. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00746-7 · Cited by 129
The Hepatic Microvascular System in Health and Its Response to Toxicants
Mccuskey, R. S. (2008) · The Anatomical Record · doi:10.1002/ar.20663 · Cited by 128
Kim, Y., & Rajagopalan, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015456 · Cited by 125
Harris, A. J., Dial, S. L., & Casciano, D. A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.11.014 · Cited by 123
de Longueville, F. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg196 · Cited by 123
Snykers, S., Vanhaecke, T., Papeleu, P., Luttun, A., Jiang, Y., Vander Heyden, Y., Verfaillie, C., & Rogiers, V. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl058 · Cited by 123
Self-citationPapeleu, P., Vanhaecke, T., Henkens, T., Elaut, G., Vinken, M., Snykers, S., & Rogiers, V. (2006) · Cytochrome P450 Protocols · doi:10.1385/1-59259-998-2:229 · Cited by 122
Self-citationWhich in vitro models could be best used to study hepatocyte polarity?
Decaens, C., Durand, M., Grosse, B., & Cassio, D. (2008) · Biology of the Cell · doi:10.1042/bc20070127 · Cited by 121
In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
Gomez-Lechon, M. J., Lahoz, A., Gombau, L., Castell, J. V., & Donato, M. T. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208910 · Cited by 120 · cited 2×
“tant part of these in vitro models (Elaut et al. 2006; Gomez-Lechon et al. 2010; Vinken et al. 2006b; Papeleu et al. 2002; Tuschl et al. 2007).”
BackgroundLu, H., Chua, K. N., Zhang, P., Lim, W. S., Ramakrishna, S., Leong, K. W., & Mao, H. (2005) · Acta Biomaterialia · doi:10.1016/j.actbio.2005.04.003 · Cited by 119
Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity
Baudoin, R., Corlu, A., Griscom, L., Legallais, C., & Leclerc, É. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.11.004 · Cited by 119
DNA hypermethylation as a chemotherapy target
Ren, J., Singh, B. N., Huang, Q., Li, Z., Gao, Y., Mishra, P., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.02.003 · Cited by 119
KUPFFER CELL-MEDIATED IL-2 SUPPRESSION OF CYP3A ACTIVITY IN HUMAN HEPATOCYTES
Sunman, J. A., Hawke, R. L., LeCluyse, E. L., & Kashuba, A. D. M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.359 · Cited by 119 · cited 1×
“Co-cultures of hepatocytes and other primary non-parenchymal liver cells, even originating from distinct species, were established using, for example, stellate cells, Kupffer cells, liver sinusoidal endothelial cells (LSECs) and rat liver epithelial cells of biliary origin (rLECs) (Goulet et al. 1988; Morin and Norman…”
BackgroundMechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine
Champion, C., Guianvarc’h, D., Sénamaud‐Beaufort, C., Jurkowska, R. Z., Jeltsch, A., Ponger, L., Arimondo, P. B., & Guieysse‐Peugeot, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012388 · Cited by 118
Garside, H., Stevens, A., Farrow, S., Normand, C., Houle, B., Berry, A., Maschera, B., & Ray, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407309200 · Cited by 118
Tuschl, G., & Mueller, S. O. (2005) · Toxicology · doi:10.1016/j.tox.2005.10.017 · Cited by 117
Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A
Codd, R., Braich, N., Liu, J., Soe, C. Z., & Pakchung, A. A. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.026 · Cited by 117
Vinci, B., Duret, C., Klieber, S., Gerbal‐Chaloin, S., Sa‐Cunha, A., Laporte, S., Suc, B., Maurel, P., Ahluwalia, A., & Daujat‐Chavanieu, M. (2011) · Biotechnology Journal · doi:10.1002/biot.201000326 · Cited by 116
Kang, K. W., Cho, I. J., Lee, C. H., & Kim, S. G. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.53 · Cited by 114
Lee, Y. H., Yano, M., Liu, S. Y., Matsunaga, E., Johnson, P. F., & Gonzalez, F. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1383 · Cited by 113
Biology and pathobiology of gap junctional channels in hepatocytes
Vinken, M., Henkens, T., Rop, E. D., Fraczek, J., Vanhaecke, T., & Rogiers, V. (2007) · Hepatology · doi:10.1002/hep.22049 · Cited by 112
Self-citationYao, Y.-L., & Yang, W.-M. (2011) · BioMed Research International · doi:10.1155/2011/146493 · Cited by 110 · cited 1×
“A reversible acetylation switch also modifies the biological activity of non-histone proteins such as TFs, DNA repair enzymes, cell cycle regulators, molecular chaperones and structural proteins, by regulating their stability, localization, DNA-binding ability and protein– protein interactions (Glozak et al. 2005; Ock…”
BackgroundRodríguez‐Antona, C., Bort, R., Jover, R., Tindberg, N., Ingelman‐Sundberg, M., Gómez-Lechón, M. J., & Castell, J. V. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1180 · Cited by 109 · cited 1×
“resulted in a superior activation of CYP3A4, CYP3A5 and CYP3A7 genes, compared with the effect exerted by each of these LETFs individually (Rodriguez-Antona et al. 2003).”
BackgroundPatra, S. K., Patra, A., Rizzi, F., Ghosh, T. C., & Bettuzzi, S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9118-y · Cited by 109
Maher, J. M., Slitt, A. L., Callaghan, T. N., Cheng, X., Cheung, C., Gonzalez, F. J., & Klaassen, C. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.016 · Cited by 109
Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity
Park, B. K., Laverty, H., Srivastava, A., Antoine, D. J., Naisbitt, D. J., & Williams, D. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.011 · Cited by 109
Metzger, S., Halaas, J. L., Breslow, J. L., & Sladek, F. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85491-1 · Cited by 108
C/EBPs: recipients of extracellular signals through proteome modulation
Nerlov, C. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.02.002 · Cited by 108 · cited 1×
“Each family is represented by at least two isoforms, which exhibit distinct spatiotemporal expression and functions (Schrem et al. 2002; Hwang-Verslues and Sladek 2010; Kaestner 2010; Nerlov 2008).”
BackgroundCosta, R. H., Lai, E., Grayson, D. R., & Darnell, J. E. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.81 · Cited by 106
Guyomard, C., Rialland, L., Frémond, B., Chesné, C., & Guillouzo, A. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0299 · Cited by 106
WANG, K., SHINDOH, H., INOUE, T., & HORII, I. (2002) · The Journal of Toxicological Sciences · doi:10.2131/jts.27.229 · Cited by 106
Bakker, J., Lin, X., & Nelson, W. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203009200 · Cited by 106 · cited 1×
“DNMT inhibition had an equally positive effect on the mRNA levels of the phase II biotransformation enzymes glutathione S-transferase pi 1 (Gstp1) and the UDP-glucuronosyltransferases UGT1A6 and UGT2B15, while simultaneously downregulating UGT2B28 (Dannenberg and Edenberg 2006; Bakker et al. 2002).”
BackgroundMolecular Pathology of Liver Diseases
Nelson, J. E., Trinder, D., & Kowdley, K. V. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4 · Cited by 105
Long-term culture of hepatocytes: Effect of hormones on enzyme activities and metabolic capacity
Dich, J., Vind, C., & Grunnet, N. (1988) · Hepatology · doi:10.1002/hep.1840080109 · Cited by 105
Functional Association between CBP and HNF4 inTrans-activation
Yoshida, E., Aratani, S., Itou, H., Miyagishi, M., Takiguchi, M., Osumu, T., Murakami, K., & Fukamizu, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7871 · Cited by 104
ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
Tsaioun, K., Bottlaender, M., Mabondzo, A., & the Alzheimer's Drug Discovery Foundation (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s1 · Cited by 103 · cited 1×
“cells or tissues, respectively (Bass et al. 2009; Tsaioun et al. 2009).”
Wilkening, S., & Bader, A. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10085 · Cited by 102 · cited 1×
“However, the most commonly used hepatic cell line, that is, human hepatoma HepG2 cells, undergoes a substantial loss of liver cell functions, particularly the expression of phase I (CYPs) enzymes and drug transporters is decreased (Boess et al. 2003; Castell et al. 2006; Harris et al. 2004; Wang et al. 2002; Wilkening…”
BackgroundTuschl, G., Hrach, J., Walter, Y., Hewitt, P. G., & Mueller, S. O. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.05.015 · Cited by 102
Mesnil, M., Fraslin, J.-M., Piccoli, C., Yamasaki, H. R., & Guguen‐Guillouzo, C. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90292-8 · Cited by 101
Involvement of Cell Junctions in Hepatocyte Culture Functionality
Vinken, M., Papeleu, P., Snykers, S., De Rop, E., Henkens, T., Chipman, J. K., Rogiers, V., & Vanhaecke, T. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600599273 · Cited by 101
Self-citation
Research works printed but not linked: 1
- Nishimura M, Ejiri Y, Kishimoto S, Suzuki S, Satoh T, Horie T, Narimatsu S, Naito S (2011) Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates. Drug Metab Pharmacokinet 26(2):137–144 · DOI
Cited by
McGill, M. R., & Jaeschke, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1007-6 · Cited by 704
“Phenobarbital), can be added to the culture medium (171,174,175).”
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture
Gieseck III, R. L., Hannan, N. R. F., Bort, R., Hanley, N. A., Drake, R. A. L., Cameron, G. W. W., Wynn, T. A., & Vallier, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086372 · Cited by 197
“This is suggestive of contact-dependent apoptosis similar to that seen in low density PHH dedifferentiation [1,2].”
Engineering a perfusable 3D human liver platform from iPS cells
Schepers, A., Li, C., Chhabra, A., Seney, B. T., & Bhatia, S. (2016) · Lab on a Chip · doi:10.1039/c6lc00598e · Cited by 176
Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1694-y · Cited by 141
“Furthermore, following isolation, primary human hepatocytes undergo a rapid dedifferentiation process in which many unique hepatocyte characteristics are lost, reducing the physiological relevance of the model (Fraczek et al. 2013; Godoy et al. 2013).”
BackgroundInfluential
Metadata
- Authors
- Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Corresponding author
- Fraczek, J.
- Venue
- Archives of Toxicology
- Published
- 2012-12-15
- Volume
- 87
- Issue
- 4
- Pages
- 577-610
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2018187848
- Cited by
- 119
- References
- 422
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 9 · 2014: 14 · 2013: 5
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- primary hepatocyte culture, hepatocyte dedifferentiation, preclinical safety, drug toxicity, high-throughput screening, alternatives to animal testing, long-term hepatocyte culture
- MeSH terms
- Animals, Animal Testing Alternatives, Cells, Cultured, Drug Evaluation, Preclinical, Humans, Xenobiotics, Apoptosis, Hepatocytes, Mice, Rats, Cell Dedifferentiation, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.